31-Dec-20 | 31-Dec-19 | 31-Dec-18 | 31-Dec-10 | 31-Dec-09 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Europe | 52.82 | 60% | 46.60 | 73% | 41.54 | 62% | 10.35 | 93% | 18.99 | 99% |
Rest of World | 34.91 | 40% | 17.46 | 27% | 25.24 | 38% | n/a | n/a | n/a | n/a |
USA | n/a | n/a | n/a | n/a | n/a | n/a | 0.81 | 7% | 0.13 | 1% |
Total | 87.73 | 100% | 64.06 | 100% | 66.78 | 100% | 11.15 | 100% | 19.12 | 100% |
Profit Before Tax | ||||||||||
Unanalysed | (6.57) | 100% | (20.89) | 100% | 5.01 | 100% | (11.80) | 100% | (5.09) | 100% |
Total | (6.57) | 100% | (20.89) | 100% | 5.01 | 100% | (11.80) | 100% | (5.09) | 100% |
31-Dec-20 | 31-Dec-19 | 31-Dec-18 | 31-Dec-10 | 31-Dec-09 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Bioprocessing / Commercial development | n/a | n/a | n/a | n/a | 40.50 | 61% | n/a | n/a | n/a | n/a |
Biotechnology research and development | n/a | n/a | n/a | n/a | n/a | n/a | 11.15 | 100% | 19.12 | 100% |
License fees & incentives | n/a | n/a | n/a | n/a | 26.27 | 39% | n/a | n/a | n/a | n/a |
Platform | 87.12 | 99% | 51.00 | 80% | n/a | n/a | n/a | n/a | n/a | n/a |
Product | 0.61 | 1% | 13.06 | 20% | n/a | n/a | n/a | n/a | n/a | n/a |
Total | 87.73 | 100% | 64.06 | 100% | 66.78 | 100% | 11.15 | 100% | 19.12 | 100% |
Profit Before Tax | ||||||||||
Biotechnology research and development | n/a | n/a | n/a | n/a | n/a | n/a | (11.80) | 100% | (5.09) | 100% |
Unanalysed | (6.57) | n/a | (20.89) | n/a | 5.01 | n/a | n/a | n/a | n/a | n/a |
Total | (6.57) | n/a | (20.89) | n/a | 5.01 | n/a | (11.80) | 100% | (5.09) | 100% |
You are here: research